Drug
Xalacom clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 5
- first study started
- 2002
How studies write it
Studies that test it under each name
Name
- Xalacom
- 10
Studies by the year they started
10 studies that test it; most in 2005 (4)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 5
- Phase 4
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (6) · Ophthalmic Consultants Centres, Canada (1) · Aristotle University Of Thessaloniki (1) · University of Campinas, Brazil (1) · Pfizer (1)
Often tested with
Tested in the same studies.
Latanoprost (3) · Timolol (2) · Dorzolamide-timolol combination (1) · Duotrav (1) · Ganfort (1)
Studies
Open first, then newest update. How each study uses Xalacom is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).CompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00383019Written as Xalacom
- Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.CompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00143208Written as Xalacom
- A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00159653Written as Xalacom
- Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular HypertensionCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00219596Written as Xalacom
- A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ GlaucomaCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00140049Written as Xalacom
- A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00277498Written as Xalacom
- A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle GlaucomaCompletedPhase 4Ophthalmic Consultants Centres, CanadaNCT00887029Written as Xalacom (latanoprost-timolol ophthalmic drops)
- Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination TherapyCompletedPhase 4Aristotle University Of ThessalonikiNCT01779284Written as Latanoprost/Timolol therapy
- Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAGCompletedPhase 4University of Campinas, BrazilNCT01978015Written as latanoprost and maleate timolol fixed combination
- A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular HypertensionCompletedPhase 3PfizerNCT00150267Written as Xalacom